Prana Biotechnology (Nasdaq: PRAN) today announced that it has secured a key patent protecting its clinical drug asset PBT2, with ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE